Skip to main content
Erschienen in: European Radiology 8/2016

11.11.2015 | Hepatobiliary-Pancreas

Incidence and risk factors of early arterial blood flow stasis during first radioembolization of primary and secondary liver malignancy using resin microspheres: an initial single-center analysis

verfasst von: Claus Christian Pieper, Winfried A. Willinek, Daniel Thomas, Hojjat Ahmadzadehfar, Markus Essler, Jennifer Nadal, Kai E. Wilhelm, Hans Heinz Schild, Carsten Meyer

Erschienen in: European Radiology | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To retrospectively determine incidence of early arterial blood flow stasis and its influencing factors during resin-based radioembolization (RE) of liver tumours.

Methods

Data of patients undergoing resin-based RE from 06/2006–12/2013 were reviewed. Second RE procedures of the same liver lobe were excluded. 90-yttrium dose was calculated according to the body surface area method. Data were categorized according to RE without full dose application because of early stasis and with full dose application. Clinical/procedural characteristics were recorded. Logistic regression was performed to identify associations between clinical/procedural characteristics and early stasis.

Results

362 patients [220 male; mean age 62 years (range 26–90)] underwent 416 RE sessions with early stasis occurring in 103 REs (24.8 %). Highest incidence and degree of stasis were observed in breast cancer metastases [42.6 % (20/47); 55.8 % of mean intended dose administered]. Independent risk factors were: metastasized breast cancer (odds ratio [OR] 2.18, p = 0.02), liver tumour-burden <25 % and 25–50 % (ORs 5.33, 15.64; p < 0.0001), tumour hypovascularity (OR 2.70, p = 0.04), previous bevacizumab therapy (OR 2.79, p = 0.0009) and concurrent chemotherapy (OR 8.69, p < 0.0001).

Conclusion

Early stasis was observed in 24.8 % of resin-based REs. In the presence of the identified risk factors, extra care should be taken during microsphere administration.

Key Points

Early arterial blood flow stasis is a known problem of resin-based RE.
The study showed that early stasis occurs in 25 % of REs.
Several clinical and procedural factors are associated with early stasis.
In patients at risk extra care should be taken during RE.
Literatur
1.
Zurück zum Zitat Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JF, Goin K, Van Buskirk M, Thurston K (2005) Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 16:205–213CrossRefPubMed Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JF, Goin K, Van Buskirk M, Thurston K (2005) Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 16:205–213CrossRefPubMed
2.
Zurück zum Zitat Salem R, Lewandowski RJ, Atassi B, Gordon SC, Gates VL, Barakat O, Sergie Z, Wong CY, Thurston KG (2005) Treatment of unresectable hepatocellular carcinoma with useof 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 16:1627–1639CrossRefPubMed Salem R, Lewandowski RJ, Atassi B, Gordon SC, Gates VL, Barakat O, Sergie Z, Wong CY, Thurston KG (2005) Treatment of unresectable hepatocellular carcinoma with useof 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 16:1627–1639CrossRefPubMed
3.
Zurück zum Zitat Zurkiya O, Ganguli S (2014) Beyond hepatocellular carcinoma and colorectal metastasis: the expanding applications of radioembolization. Front Oncol 16:150 Zurkiya O, Ganguli S (2014) Beyond hepatocellular carcinoma and colorectal metastasis: the expanding applications of radioembolization. Front Oncol 16:150
4.
Zurück zum Zitat Mahnken AH, Spreafico C, Maleux G, Helmberger T, Jakobs TF (2013) Standards of practice in transarterialradioembolization. Cardiovasc Intervent Radiol 36:613–622CrossRefPubMed Mahnken AH, Spreafico C, Maleux G, Helmberger T, Jakobs TF (2013) Standards of practice in transarterialradioembolization. Cardiovasc Intervent Radiol 36:613–622CrossRefPubMed
5.
Zurück zum Zitat Murthy R, Xiong H, Nunez R, Cohen AC, Barron B, Szklaruk J, Madoff DC, Gupta S, Wallace MJ, Ahrar K, Hicks ME (2005) Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol 16:937–945CrossRefPubMed Murthy R, Xiong H, Nunez R, Cohen AC, Barron B, Szklaruk J, Madoff DC, Gupta S, Wallace MJ, Ahrar K, Hicks ME (2005) Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol 16:937–945CrossRefPubMed
6.
Zurück zum Zitat Lam MG, Banerjee S, Louie JD, Abdelmaksoud MH, Iagaru AH, Ennen RE, Sze DY (2013) Root cause analysis of gastroduodenal ulceration after yttrium-90 radioembolization. Cardiovasc Intervent Radiol 36:1536–1547CrossRefPubMed Lam MG, Banerjee S, Louie JD, Abdelmaksoud MH, Iagaru AH, Ennen RE, Sze DY (2013) Root cause analysis of gastroduodenal ulceration after yttrium-90 radioembolization. Cardiovasc Intervent Radiol 36:1536–1547CrossRefPubMed
7.
Zurück zum Zitat Piana PM, Bar V, Doyle L, Anne R, Sato T, Eschelman DJ, McCann JW, Gonsalves CF, Brown DB (2014) Early arterial stasis during resin-based yttrium-90 radioembolization: incidence and preliminary outcomes. HPB (Oxford) 16:336–341CrossRef Piana PM, Bar V, Doyle L, Anne R, Sato T, Eschelman DJ, McCann JW, Gonsalves CF, Brown DB (2014) Early arterial stasis during resin-based yttrium-90 radioembolization: incidence and preliminary outcomes. HPB (Oxford) 16:336–341CrossRef
8.
Zurück zum Zitat Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, Benson A 3rd, Espat J, Bilbao JI, Sharma RA, Thomas JP, Coldwell D (2007) Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 68:13–23CrossRefPubMed Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, Benson A 3rd, Espat J, Bilbao JI, Sharma RA, Thomas JP, Coldwell D (2007) Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 68:13–23CrossRefPubMed
9.
Zurück zum Zitat Murthy R, Nunez R, Szklaruk J, Erwin W, Madoff DC, Gupta S, Ahrar K, Wallace MJ, Cohen A, Coldwell DM, Kennedy AS, Hicks ME (2005) Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 25:S41–S55CrossRefPubMed Murthy R, Nunez R, Szklaruk J, Erwin W, Madoff DC, Gupta S, Ahrar K, Wallace MJ, Cohen A, Coldwell DM, Kennedy AS, Hicks ME (2005) Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 25:S41–S55CrossRefPubMed
10.
Zurück zum Zitat Riaz A, Lewandowski RJ, Kulik LM, Mulcahy MF, Sato KT, Ryu RK, Omary RA, Salem R (2009) Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review. J Vasc Interv Radiol 20:1121–1130CrossRefPubMed Riaz A, Lewandowski RJ, Kulik LM, Mulcahy MF, Sato KT, Ryu RK, Omary RA, Salem R (2009) Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review. J Vasc Interv Radiol 20:1121–1130CrossRefPubMed
11.
Zurück zum Zitat Morsbach F, Sah BR, Spring L, Puippe G, Gordic S, Seifert B, Schaefer N, Pfammatter T, Alkadhi H, Reiner CS (2014) Perfusion CT best predicts outcome after radioembolization of liver metastases: a comparison of radionuclide and CT imaging techniques. Eur Radiol 24:1455–1465CrossRefPubMed Morsbach F, Sah BR, Spring L, Puippe G, Gordic S, Seifert B, Schaefer N, Pfammatter T, Alkadhi H, Reiner CS (2014) Perfusion CT best predicts outcome after radioembolization of liver metastases: a comparison of radionuclide and CT imaging techniques. Eur Radiol 24:1455–1465CrossRefPubMed
12.
Zurück zum Zitat Naymagon S, Warner RRP, Patel K, Harpaz N, Machac J, Weintraub JL et al (2010) Gastroduodenal ulceration associated with radioembolization for the treatment of hepatic tumors: an institutional experience and review of the literature. Dig Dis Sci 55:2450–2458CrossRefPubMed Naymagon S, Warner RRP, Patel K, Harpaz N, Machac J, Weintraub JL et al (2010) Gastroduodenal ulceration associated with radioembolization for the treatment of hepatic tumors: an institutional experience and review of the literature. Dig Dis Sci 55:2450–2458CrossRefPubMed
13.
Zurück zum Zitat Garin E, Rolland Y, Boucher E (2013) Pre-therapeutic dosimetry evaluation and selective internal radiation therapy of hepatocellular carcinoma using yttrium-90-loaded microspheres. J Hepatol 58:1055–1056CrossRefPubMed Garin E, Rolland Y, Boucher E (2013) Pre-therapeutic dosimetry evaluation and selective internal radiation therapy of hepatocellular carcinoma using yttrium-90-loaded microspheres. J Hepatol 58:1055–1056CrossRefPubMed
14.
Zurück zum Zitat Dancey JE, Shepherd FA, Paul K, Sniderman KW, Houle S, Gabrys J et al (2000) Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Ymicrospheres. J Nucl Med 41:1673–1681PubMed Dancey JE, Shepherd FA, Paul K, Sniderman KW, Houle S, Gabrys J et al (2000) Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Ymicrospheres. J Nucl Med 41:1673–1681PubMed
15.
Zurück zum Zitat Sangro B, Iñarrairaegui M, Bilbao JI (2013) Reply to: "Pre-therapeutic dosimetry evaluation and selective internal radiation therapy of hepatocellular carcinoma using yttrium-90-loaded microspheres". J Hepatol 58:1056–1057CrossRefPubMed Sangro B, Iñarrairaegui M, Bilbao JI (2013) Reply to: "Pre-therapeutic dosimetry evaluation and selective internal radiation therapy of hepatocellular carcinoma using yttrium-90-loaded microspheres". J Hepatol 58:1056–1057CrossRefPubMed
16.
Zurück zum Zitat Tanimura A, Tanaka S, Kitazono M (1986) Superficial intimal injury of the rabbit carotid artery induced by distilled water. Virchows Arch B Cell Pathol Incl Mol Pathol 51:197–205CrossRefPubMed Tanimura A, Tanaka S, Kitazono M (1986) Superficial intimal injury of the rabbit carotid artery induced by distilled water. Virchows Arch B Cell Pathol Incl Mol Pathol 51:197–205CrossRefPubMed
18.
Zurück zum Zitat Sogo N, Wilkinson IB, MacCallum H, Khan SQ, Strachan FE, Newby DE, Megson IL, Webb DJ (2000) A novel S-nitrosothiol (RIG200) causes prolonged relaxation in dorsal hand veins with damaged endothelium. Clin Pharmacol Ther 68:75–81CrossRefPubMed Sogo N, Wilkinson IB, MacCallum H, Khan SQ, Strachan FE, Newby DE, Megson IL, Webb DJ (2000) A novel S-nitrosothiol (RIG200) causes prolonged relaxation in dorsal hand veins with damaged endothelium. Clin Pharmacol Ther 68:75–81CrossRefPubMed
Metadaten
Titel
Incidence and risk factors of early arterial blood flow stasis during first radioembolization of primary and secondary liver malignancy using resin microspheres: an initial single-center analysis
verfasst von
Claus Christian Pieper
Winfried A. Willinek
Daniel Thomas
Hojjat Ahmadzadehfar
Markus Essler
Jennifer Nadal
Kai E. Wilhelm
Hans Heinz Schild
Carsten Meyer
Publikationsdatum
11.11.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 8/2016
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-015-4076-6

Weitere Artikel der Ausgabe 8/2016

European Radiology 8/2016 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.